Updated:
Daybreak Partners
Daybreak Partners is a Palm Beach venture firm backing health-tech companies like Lemonaid Health and VIDA, with no public AUM or team bios.
Daybreak Partners
Partner to growth companies | We partner with entrepreneurs to help turn their vision into a successful company.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Palm Beach
Corporate office
Palm Beach, FL, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Daybreak Partners?
The firm does not publicly name a founder, managing partner, or investment committee member. Its website, the sole known public presence, lists no personnel. This means capital-allocation authority and investment decision-making rest with undisclosed principals, making reference checks with portfolio founders the only viable path to identifying decision-makers.
How does Daybreak Partners source proprietary deal flow?
The firm's website exclusively invites entrepreneurs to initiate contact through a 'Get in touch' portal, with no mention of scout networks, banker relationships, or conference strategies. This suggests a founders-first inbound sourcing model, where deal flow depends on reputation among health-tech and future-of-work founders rather than institutional origination channels.
Does Daybreak Partners participate in fund commitments or only direct deals?
There is no publicly available information on whether Daybreak makes fund commitments alongside its direct investments. The small known portfolio — fewer than ten companies listed on the site — is entirely composed of direct company stakes, with no reference to LP positions in other venture funds.
What investment stages does Daybreak Partners typically target?
The portfolio suggests early-stage venture activity, with companies like Lemonaid Health and Sora Union fitting the venture-growth profile. Altss research flags the strategy as spanning early-stage, seed, and expansion or late-stage venture, though the firm itself does not publicly declare a stage mandate.
Which sectors does Daybreak Partners explicitly avoid?
No explicit exclusion list has been published. The website emphasizes healthcare-technology intersection and the future of work, implying limited appetite for general enterprise SaaS, consumer internet, or industrial technology outside those themes. The absence of any biotech or medical device portfolio companies further narrows the likely sector focus.
What is Daybreak Partners' known posture on co-investments alongside external GPs?
Nothing public addresses co-investment practices. Portfolio company press releases and regulatory filings would be the sole source for confirming whether Daybreak leads rounds, follows lead investors, or participates exclusively in syndicates alongside other venture firms.
How is Daybreak Partners structurally organized — family office, venture firm, or something else?
Altss research classifies Daybreak as an asset manager with a private equity subtype. It does not self-identify as a family office, multi-family office, or registered investment advisor on its website. The absence of any named principals makes it impossible to determine whether the firm manages third-party capital or solely proprietary principal money.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: